Humana Inc.
HUM
Pozycja w akcjach
#491
Humana Inc., a prominent health and well-being enterprise, operates across the... Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Cena akcji
$414.60
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$49.79B
Zmiana (1 dzień)
0.18%
Zmiana (1 rok)
45.99%
Kraj
US
Handel Humana Inc. (HUM)
Kategoria
Healthcare
Wskaźnik P/E dla Humana Inc. (HUM)
Wskaźnik P/E na dzień October 2026 TTM: 40.15
Według najnowszych raportów finansowych i ceny akcji Humana Inc., obecny wskaźnik P/E (TTM) wynosi 40.15. Na koniec 2023 wskaźnik P/E wynosił 22.78.
Historia wskaźnika P/E dla Humana Inc. od 2000 do 2026
Wskaźnik P/E na koniec każdego roku
| Rok | Wskaźnik P/E | Zmień |
|---|---|---|
| 2026 (TTM) | 40.15 | 58.44% |
| 2024 | 25.34 | 11.24% |
| 2023 | 22.78 | -1.27% |
| 2022 | 23.08 | 13.38% |
| 2021 | 20.35 | 26.35% |
| 2020 | 16.11 | -11.25% |
| 2019 | 18.15 | -22.44% |
| 2018 | 23.40 | 59.83% |
| 2017 | 14.64 | -70.50% |
| 2016 | 49.64 | 137.40% |
| 2015 | 20.91 | 8.29% |
| 2014 | 19.31 | 46.20% |
| 2013 | 13.21 | 45.62% |
| 2012 | 9.07 | -11.20% |
| 2011 | 10.21 | 22.21% |
| 2010 | 8.36 | 18.28% |
| 2009 | 7.07 | -26.63% |
| 2008 | 9.63 | -36.11% |
| 2007 | 15.07 | -19.06% |
| 2006 | 18.62 | -34.53% |
| 2005 | 28.45 | 67.66% |
| 2004 | 16.97 | 4.69% |
| 2003 | 16.21 | 37.75% |
| 2002 | 11.76 | -29.15% |
| 2001 | 16.61 | -41.20% |
| 2000 | 28.24 | 0.00% |
Wskaźnik P/E dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/E | Różnica wskaźnika P/E | Kraj |
|---|---|---|---|
| 22.58 | -43.76% |
US
|
|
| 23.60 | -41.22% |
US
|
|
| 19.03 | -52.61% |
US
|
|
| 11.94 | -70.26% |
US
|
|
| - | - |
US
|
Jak odczytywać wskaźnik P/E?
Wskaźnik Cena/Zysk (P/E) mierzy relację między ceną akcji firmy a jej zyskiem na akcję.
Niski, ale dodatni P/E oznacza firmę osiągającą wysokie zyski względem obecnej wyceny i może być niedowartościowana. Wysoki ujemny (bliski 0) P/E wskazuje na duże straty.
Firmy z P/E powyżej 30 lub ujemnym uznaje się zazwyczaj za "akcje wzrostowe", czyli inwestorzy oczekują wzrostu lub przyszłych zysków.
Firmy z dodatnim P/E poniżej 10 uznaje się za "akcje wartościowe", co oznacza, że są już bardzo dochodowe, ale bez dużego potencjału wzrostu.